Advances in Oncologic Hematology
Oncologic hematology continuously evolves, marked by significant advances in both screening and therapeutic strategies for hematologic malignancies. Novel targeted therapies are redefining the landscape, offering improved outcomes for patients with diverse forms of cancer. Clinical trials are prolifically evaluating promising therapeutic strategies